
rs and help improve R&D efficiency for innovative pediatric drugs in the pipeline through advanced interactions and rolling data submissions. Efforts will also be made to su
;Drug regulators will also enhance early and continuous communication with developers and help improve R&D efficiency for innovative pediatric drugs in the pipeline through advanced interactions a
当前文章:http://fa9ob1.mubensai.cn/uvau/jn22kl.html
发布时间:11:12:29
推荐阅读